Indefinite Delivery Contract SPE2DX15D9102

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at up to $4,999,999, enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of military healthcare facilities and veterans' medical centers nationwide. The contract is not associated with any set-aside designations, allowing DMS Pharmaceutical Group to leverage its small business status to secure direct federal awards across multiple product categories. The period of performance extends through December 31, 2025.

The task orders issued under this IDC cover a diverse portfolio of pharmaceutical items, such as Xolair, Trikafta, Keytruda, Botox, Nucala, and various other specialized medications, as well as common drugs like escitalopram, sertraline, and lisinopril. These delivery orders are predominantly firm fixed-price and support the DLA's role in providing centralized pharmaceutical procurement and distribution services to the Department of Defense's medical supply chain. The place of performance for all task orders is DMS Pharmaceutical Group's facility in Park Ridge, Illinois.